Ascendis Pharma A/S (FRA:A71)
Germany · Delayed Price · Currency is EUR 190.00
+1.00 (0.53%)
At close: Mar 27, 2026
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of €11.56 billion as of March 27, 2026. Its market cap has increased by 37.76% in one year.
Market Cap
11.56B
Enterprise Value
11.82B
Revenue
720.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
€190.00
Market Cap Chart
Since January 28, 2015, Ascendis Pharma's market cap has increased from 364.37M to 11.56B, an increase of 3,072.22%. That is a compound annual growth rate of 36.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 11.56B | 3.69% |
| Dec 31, 2025 | 11.15B | 40.17% |
| Dec 31, 2024 | 7.95B | 23.38% |
| Dec 29, 2023 | 6.45B | 0.95% |
| Dec 30, 2022 | 6.38B | -4.90% |
| Dec 31, 2021 | 6.71B | -8.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest Aktiengesellschaft | 1.44B |
| Darwin AG | 92.40M |
| 2invest AG | 62.87M |
| Biomark Diagnostics | 37.83M |
| co.don AG | 360.77K |
| bioXXmed AG | 323.52K |
| Paion AG | 232.56K |
| MagForce AG | 137.58K |